HOME >> BIOLOGY >> NEWS
Overweight Cats Risk Disease And Premature Death, Cornell Study Finds

ITHACA, N.Y. -- Seriously overweight cats are more likely to suffer diabetes mellitus, lameness and non-allergic skin conditions, a Cornell University veterinarian's four-year follow-up to a feline obesity study has shown.

Most likely to be tubby are neutered, apartment-dwelling, mixed breed cats eating prescription cat food.

"The original obesity study and the follow-up confirm what veterinarians and cat owners have suspected for a long time," said Janet M. Scarlett, D.V.M., associate professor of epidemiology in Cornell's College of Veterinary Medicine. "Too much extra weight is not healthy for the cats, but being very thin can be a problem, too."

Scarlett was a collaborator, along with veterinary nutritionist Susan Donoghue, in the landmark 1989 study of 2,000 cats at 31 veterinary clinics in the Northeast, as well as the principal investigator of the tracking study. The Waltham Centre for Pet Nutrition in the United Kingdom funded the first study, which found that about 25 percent of cats brought to veterinarians are overweight: 20 percent were ranked as "heavy" by veterinarians and 5 percent were considered "obese." Slightly more pet owners -- about 29 percent -- thought their cats were overweight in the same survey.

Ralston Purina Co., the American pet food manufacturer, funded the four-year follow-up, in which Cornell veterinary students called as many of the original pet owners as they could locate and asked about the cats' health. Researchers also reviewed veterinarians' medical records for the animals in the first survey. Among the findings:

  • Overweight cats, including those considered "heavy" and "obese," are four-and-a-half times more likely to develop diabetes mellitus, compared to optimal weight cats.

  • Obese cats are seven times more likely to require veterinary care for lameness, caused by joint diseases such as arthritis or muscle injuries, compared to optimal weight cats. Heavy cats
    '"/>


Contact: Roger Segelken
hrs2@cornell.edu
607-255-9736
Cornell University News Service
1-Apr-1997


Page: 1 2 3 4

Related biology news :

1. Disease diagnosis, drug development focus of UH profs biochip research
2. Disease-resistant papaya saves Hawaiian papaya industry
3. APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11
4. 1st International Conference on Cell Therapy for Cardiovascular Disease
5. Disease threatens cucumbers, pumpkins, and other vine crops
6. Disease-fighters in our mouths provide clues to enhancing the immune system
7. International Conference on Emerging Infectious Diseases
8. NIH establishes Rare Diseases Clinical Research Network
9. Shedding Light on Disease: A Briefing for Journalists
10. Disease-causing genetic mutations in sperm increase with mens age
11. World Congress on Huntingtons Disease to meet in Toronto, August 16-19, 2003

Post Your Comments:
(Date:7/23/2014)... The drought that has the entire country in its grip ... may also be responsible for the proliferation of a heat-loving ... rivers and hot springs, which the drought has made warmer ... died of an infection caused by this parasite after swimming ... the nose of an individual and travels to the brain. ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... 2014 BioCatch, the global leader ... it has been named in Gartner,s Market Guide for ... Gartner,s well-known Magic Quadrant for Web Fraud Detection. ... of several vendors to deliver passive biometric analysis and ... standard feature of at least 30% of one-stop fraud ...
Breaking Biology News(10 mins):Diseases of another kind 2Protein evolution follows a modular principle 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... BRUSSELS , July 23, 2014 regulated ... its research and development pipeline with positive topline ... brivaracetam . This study was designed to evaluate ... (100 and 200 mg/day, without titration) compared to ... patients with partial-onset seizures, not fully controlled despite ...
(Date:7/23/2014)... Calif. , July 23, 2014  Sofinnova Ventures, ... firm, today announced the closing of Sofinnova Venture Partners ... and in excess of the initial fund target of ... entrepreneurs build successful biotechnology companies. Consistent with recent funds, ... promising later stage clinical programs, along with select investments ...
(Date:7/23/2014)... 23, 2014 OncLive® is pleased ... has joined its Strategic Alliance Partnership program. ... program, UNC Lineberger will have the opportunity to ... of its cutting-edge research initiatives, community-directed cancer prevention ... will work with OncLive to educate their peers ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: